Skip to main content
Log in

NOD2 exonic variations in Iranian Crohn's disease patients

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

The NOD2 gene is known to have a strong association with Crohn’s disease, but different trends were reported in occurrence of NOD2 variants in distinct ethnicities. The aim of this study was to assess all exonic sequences of the NOD2 gene in Iranian Crohn's disease patients and healthy controls to identify any existing variation and evaluate their association with Crohn's disease.

Methods

A total of 90 non-related Crohn's disease patients and 120 sex- and age-matched healthy controls of Iranian origin were enrolled in this study. The participants were referred to a tertiary center in a 2-year period (2006–2008). The exonic regions of the NOD2 gene were amplified by polymerase chain reaction and evaluated by direct sequencing.

Results

A total of 21 sequence variations were identified among all exonic regions of the NOD2 gene, of which eight had an allele frequency of more than 5%. Eight new mutations (one in exon 2 and seven in exon 4) were observed. The three main variants (R702W, G908R, and 1007fs) showed allele frequencies of 13.3%, 2.2%, and 1.7%, respectively. Three new variations (P371T, A794P, and Q908H) and R702W mutation were significantly more frequent in Crohn's disease patients compared to controls.

Conclusions

Eight novel mutations were identified in the NOD2 exons, but the pathophysiological importance of these variants remains unclear. Iranian patients with their different genetic reservoirs may demonstrate some novel characteristics for disease susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347(6):417–429

    Article  PubMed  CAS  Google Scholar 

  2. Bonen DK, Cho JH (2003) The genetics of inflammatory bowel disease. Gastroenterology 124:521–536

    Article  PubMed  CAS  Google Scholar 

  3. Hugot JP, Cézard JP, Colombel JF et al (2003) Clustering of Crohn’s disease within affected sibships. Eur J Hum Genet 11:179–184

    Article  PubMed  CAS  Google Scholar 

  4. Hugot JP, Laurent-Puig P, Gower-Rousseau C et al (1996) Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 379:821–823

    Article  PubMed  CAS  Google Scholar 

  5. Satsangi J, Parkes M, Louis E et al (1996) Two stage genomewide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14:199–202

    Article  PubMed  CAS  Google Scholar 

  6. Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606

    Article  PubMed  CAS  Google Scholar 

  7. Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603

    Article  PubMed  CAS  Google Scholar 

  8. Ahmad T, Tamboli CP, Jewell DP et al (2004) Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 126:1533–1549

    Article  PubMed  CAS  Google Scholar 

  9. Girardin SE, Boneca IG, Viala J et al (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869–8872

    Article  PubMed  CAS  Google Scholar 

  10. Hugot JP (2004) Genetic origin of IBD. Inflamm Bowel Dis 10(Suppl 1):S11–S15

    Article  PubMed  Google Scholar 

  11. Lichtenberger GS, Flavell RA, Alexopoulou L (2004) Innate immunity and apoptosis in IBD. Inflamm Bowel Dis 10(Suppl 1):S58–S62

    Article  PubMed  Google Scholar 

  12. Lesage S, Zouali H, Cezard JP et al (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:745–747

    Article  Google Scholar 

  13. Economou M, Trikalinos TA, Loizou KT et al (2004) Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99:2393–2404

    Article  PubMed  CAS  Google Scholar 

  14. Cuthbert AP, Fisher SA, Mirza MM et al (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122:867–874

    Article  PubMed  CAS  Google Scholar 

  15. Vermiere S, Wild G, Kocher K et al (2002) CARD15 genetic variation in a Quebec population: prevalence, genotype–phenotype relationship, and haplotype structure. Am J Hum Genet 71:74–83

    Article  Google Scholar 

  16. Radlmayr M, Torok HP, Martin K et al (2002) The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn’s disease. Gastroenterology 122:2091–2092

    Article  PubMed  CAS  Google Scholar 

  17. Tukel T, Shalata A, Present D et al (2004) Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet 74(4):623–636

    Article  PubMed  CAS  Google Scholar 

  18. Van Heel D, Fisher S, Kirby A et al (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 13(7):763–770

    Article  PubMed  Google Scholar 

  19. Ogura Y, Inohara N, Benito A et al (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF (kappa) B. J Biol Chem 276:4812–4818

    Article  PubMed  CAS  Google Scholar 

  20. Derakhshan F, Naderi N, Farnood A et al (2008) Frequency of three common mutations of CARD15/NOD2 gene in Iranian IBD patients. Indian J Gastroenterol 27:8–11

    PubMed  Google Scholar 

  21. Aghazadeh R, Zali MR, Bahari A et al (2005) Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 20:1691–1695

    Article  PubMed  Google Scholar 

  22. Farnood A, Naderi N, Moghaddam SJ et al (2007) The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis. Int J Colorectal Dis 22:999–1003

    Article  PubMed  Google Scholar 

  23. Naderi N, Farnood A, Habibi M et al (2008) Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 23(12):1816–1822

    Article  PubMed  CAS  Google Scholar 

  24. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2–6

    Article  PubMed  CAS  Google Scholar 

  25. Malchow H, Ewe K, Brandes JW et al (1984) European Cooperative Crohn’s Disease Study (ECCDS): results of drug treatment. Gastroenterology 86:249–266

    PubMed  CAS  Google Scholar 

  26. Monkholm P, Binder V (2004) Clinical features and national history of Crohn's disease. In: Sartor RB, Sandborn WJ (eds) Kirsner's inflammatory bowel disease, 6th edn. Saunders, Philadelphia, pp 289–300

    Google Scholar 

  27. Sambrooks J, Fritsch EF, Manitis T (1992) Molecular cloning, laboratory manual. Cold Spring Harbor Laboratory Press, New York

    Google Scholar 

  28. Büning C, Genschel J, Bühner S et al (2004) Mutations in the NOD2 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther 19:1073–1078

    Article  PubMed  Google Scholar 

  29. Vavassori P, Borgiani P, Biancone L et al (2004) CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease. Inflamm Bowel Dis 10:116–121

    Article  PubMed  Google Scholar 

  30. Inoue N, Tamura K, Kinouchi Y et al (2002) Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology 123:86–91

    Article  PubMed  CAS  Google Scholar 

  31. Yamazaki K, Takazoe M, Tanaka T et al (2002) Absence of mutation in the NOD2 gene among 483 Japanese patients with Crohn’s disease. J Hum Genet 47:469–472

    Article  PubMed  CAS  Google Scholar 

  32. Figueroa C, Peralta A, Herrera L et al (2006) NOD2 and toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease. Eur Cytokine Netw 17:125–130

    PubMed  CAS  Google Scholar 

  33. Russell RK, Drummond HE, Wilson DC et al (2008) Detailed assessment of NOD2 exonic variation in inflammatory bowel disease in Scotland: implications for disease pathogenesis. Genes Immun 9:556–560, Abstract

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alma Farnood.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naderi, N., Farnood, A., Habibi, M. et al. NOD2 exonic variations in Iranian Crohn's disease patients. Int J Colorectal Dis 26, 775–781 (2011). https://doi.org/10.1007/s00384-011-1145-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-011-1145-4

Keywords

Navigation